Unknown

Dataset Information

0

Recombinant L-asparaginase 1 from Saccharomyces cerevisiae: an allosteric enzyme with antineoplastic activity.


ABSTRACT: L-asparaginase (L-ASNase) (EC 3.5.1.1) is an important enzyme for the treatment of acute lymphoblastic leukaemia. Currently, the enzyme is obtained from bacteria, Escherichia coli and Erwinia chrysanthemi. The bacterial enzymes family is subdivided in type I and type II; nevertheless, only type II have been employed in therapeutic proceedings. However, bacterial enzymes are susceptible to induce immune responses, leading to a high incidence of adverse effects compromising the effectiveness of the treatment. Therefore, alternative sources of L-ASNase may be useful to reduce toxicity and enhance efficacy. The yeast Saccharomyces cerevisiae has the ASP1 gene responsible for encoding L-asparaginase 1 (ScASNase1), an enzyme predicted as type II, like bacterial therapeutic isoforms, but it has been poorly studied. Here we characterised ScASNase1 using a recombinant enzyme purified by affinity chromatography. ScASNase1 has specific activity of 196.2?U/mg and allosteric behaviour, like type I enzymes, but with a low K0.5?=?75??M like therapeutic type II. We showed through site-directed mutagenesis that the T64-Y78-T141-K215 residues are involved in catalysis. Furthermore, ScASNase1 showed cytotoxicity for the MOLT-4 leukemic cell lineage. Our data show that ScASNase1 has characteristics described for the two subfamilies of l-asparaginase, types I and II, and may have promising antineoplastic properties.

SUBMITTER: Costa IM 

PROVIDER: S-EPMC5099943 | biostudies-literature | 2016 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Recombinant L-asparaginase 1 from Saccharomyces cerevisiae: an allosteric enzyme with antineoplastic activity.

Costa Iris Munhoz IM   Schultz Leonardo L   de Araujo Bianchi Pedra Beatriz B   Leite Mariana Silva Moreira MS   Farsky Sandra H P SH   de Oliveira Marcos Antonio MA   Pessoa Adalberto A   Monteiro Gisele G  

Scientific reports 20161108


L-asparaginase (L-ASNase) (EC 3.5.1.1) is an important enzyme for the treatment of acute lymphoblastic leukaemia. Currently, the enzyme is obtained from bacteria, Escherichia coli and Erwinia chrysanthemi. The bacterial enzymes family is subdivided in type I and type II; nevertheless, only type II have been employed in therapeutic proceedings. However, bacterial enzymes are susceptible to induce immune responses, leading to a high incidence of adverse effects compromising the effectiveness of th  ...[more]

Similar Datasets

2008-09-24 | GSE12890 | GEO
| S-EPMC11202230 | biostudies-literature
| S-EPMC1184572 | biostudies-other
| S-EPMC2435516 | biostudies-literature
| S-EPMC4671291 | biostudies-literature
| S-EPMC4909026 | biostudies-literature
| S-EPMC6375902 | biostudies-literature
| S-EPMC2268319 | biostudies-literature
| S-EPMC7790930 | biostudies-literature
2007-10-17 | GSE9232 | GEO